Effect of Vitamin A Supplementation on Iron Metabolic Homeostasis of Preschool Children in Sichuan,China
This study has been completed.
Sponsor:
Chengdu Maternal and Children's Health Care Hospital
Information provided by (Responsible Party):
Ke Chen, Chengdu Maternal and Children's Health Care Hospital
ClinicalTrials.gov Identifier:
NCT01355263
First received: May 9, 2011
Last updated: February 18, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators plan to perform a randomized, mutual-control and double-blinded cohort study to further exploit the vitamin A supplementation on iron metabolic homeostasis (including iron reserve, mobilization and absorption status in the same population) compared with solely iron and vitamin A plus iron.
| Condition | Intervention |
|---|---|
|
Iron Metabolic Homeostasis |
Drug: iron and vitamin a |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Effect of Vitamin A Supplementation on Iron Metabolic Homeostasis of Preschool Children in Sichuan,China |
Resource links provided by NLM:
Further study details as provided by Chengdu Maternal and Children's Health Care Hospital:
Primary Outcome Measures:
- hemoglobin [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
- hemoglobin [ Time Frame: six months ] [ Designated as safety issue: Yes ]
| Enrollment: | 450 |
| Study Start Date: | July 2011 |
| Study Completion Date: | August 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: iron tablet, vitamin a capsule
children in Group I received a 200,000 IU vitamin A capsule just one time initially; Group II received ferrous sulfate (element Fe 1-2 mg/kg•day) once a day for 6 months;.
|
Drug: iron and vitamin a |
Eligibility| Ages Eligible for Study: | 2 Years to 6 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- apparent health;
- Hb concentration>60 g/L;
- C-reaction protein (CRP)<10 mg/L;
- parental or guardian approval of participation in all aspects of the study; and
- parental/guardian agreement to avoid the additional use of vitamin and mineral supplements during the investigation.
Exclusion Criteria:
- does not match the inclusion criteria
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Ke Chen, headmaster, Chengdu Maternal and Children's Health Care Hospital |
| ClinicalTrials.gov Identifier: | NCT01355263 History of Changes |
| Other Study ID Numbers: | 20090221 |
| Study First Received: | May 9, 2011 |
| Last Updated: | February 18, 2013 |
| Health Authority: | China: Chengdu Hospital Authority |
Keywords provided by Chengdu Maternal and Children's Health Care Hospital:
|
vitamin a preschool children iron metabolic homeostasis supplementation effect |
Additional relevant MeSH terms:
|
Vitamin A Vitamins Iron Retinol palmitate Micronutrients Growth Substances Physiological Effects of Drugs Pharmacologic Actions |
Antioxidants Molecular Mechanisms of Pharmacological Action Protective Agents Anticarcinogenic Agents Antineoplastic Agents Therapeutic Uses Trace Elements |
ClinicalTrials.gov processed this record on May 22, 2013